Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mahadevan

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
The American Journal of Surgical Pathology|October 2, 2015
Performance of a Branch Chain RNA In Situ Hybridization Assay for the Detection of High-risk Human Papillomavirus in Head and Neck Squamous Cell CarcinomaDarcy A Kerr, Kshitij S Arora, Krishnan K Mahadevan, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|October 22, 2020
Reproductive Outcomes from Maternal Loss of Nlrp2 Are Not Improved by IVF or Embryo Transfer Consistent with Oocyte-Specific DefectSara Arian, Jessica Rubin, Imen Chakchouk, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Antigen-presenting type-I conventional dendritic cells facilitate curative checkpoint blockade immunotherapy in pancreatic cancerKrishnan K Mahadevan, Allison M Dyevoich, Yang Chen, et al.
Science (New York, N.Y.)|June 27, 2024
Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancerKrishnan K Mahadevan, Allison M Dyevoich, Yang Chen, et al.
Cancer Cell|July 22, 2022
Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancerYang Chen, Sujuan Yang, Jena Tavormina, et al.
Immunotherapy|February 10, 2018
Radiation therapy and immunotherapy: what is the optimal timing or sequencing?Maureen L Aliru, Jonathan E Schoenhals, Bhanu P Venkatesulu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 27, 2019
Quasimesenchymal phenotype predicts systemic metastasis in pancreatic ductal adenocarcinomaKrishnan K Mahadevan, Kshitij S Arora, Arnaud Amzallag, et al.
Annals of Surgical Oncology|March 30, 2016
Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine TumorsVincenzo Villani, Krishnan K Mahadevan, Matteo Ligorio, et al.
Biomaterials|November 11, 2022
Uncloaking cell-impermeant gold nanorods via tumor microenvironmental cathepsin B facilitates cancer cell penetration and potent radiosensitizationSubhiksha Raghuram, Yuri Mackeyev, Jessica Symons, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
Inhibitors of oncogenic Kras specifically prime CTLA4 blockade to transcriptionally reprogram Tregs and overcome resistance to suppress pancreas cancerKrishnan K Mahadevan, Ana S Maldonado, Bingrui Li, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
The American Journal of Surgical Pathology|October 2, 2015
Performance of a Branch Chain RNA In Situ Hybridization Assay for the Detection of High-risk Human Papillomavirus in Head and Neck Squamous Cell CarcinomaDarcy A Kerr, Kshitij S Arora, Krishnan K Mahadevan, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|October 22, 2020
Reproductive Outcomes from Maternal Loss of Nlrp2 Are Not Improved by IVF or Embryo Transfer Consistent with Oocyte-Specific DefectSara Arian, Jessica Rubin, Imen Chakchouk, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Antigen-presenting type-I conventional dendritic cells facilitate curative checkpoint blockade immunotherapy in pancreatic cancerKrishnan K Mahadevan, Allison M Dyevoich, Yang Chen, et al.
Science (New York, N.Y.)|June 27, 2024
Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancerKrishnan K Mahadevan, Allison M Dyevoich, Yang Chen, et al.
Cancer Cell|July 22, 2022
Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancerYang Chen, Sujuan Yang, Jena Tavormina, et al.
Immunotherapy|February 10, 2018
Radiation therapy and immunotherapy: what is the optimal timing or sequencing?Maureen L Aliru, Jonathan E Schoenhals, Bhanu P Venkatesulu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 27, 2019
Quasimesenchymal phenotype predicts systemic metastasis in pancreatic ductal adenocarcinomaKrishnan K Mahadevan, Kshitij S Arora, Arnaud Amzallag, et al.
Annals of Surgical Oncology|March 30, 2016
Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine TumorsVincenzo Villani, Krishnan K Mahadevan, Matteo Ligorio, et al.
Biomaterials|November 11, 2022
Uncloaking cell-impermeant gold nanorods via tumor microenvironmental cathepsin B facilitates cancer cell penetration and potent radiosensitizationSubhiksha Raghuram, Yuri Mackeyev, Jessica Symons, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
Inhibitors of oncogenic Kras specifically prime CTLA4 blockade to transcriptionally reprogram Tregs and overcome resistance to suppress pancreas cancerKrishnan K Mahadevan, Ana S Maldonado, Bingrui Li, et al.
Pageof 6